CN104436147A - Medicine composition for treating chloasma - Google Patents
Medicine composition for treating chloasma Download PDFInfo
- Publication number
- CN104436147A CN104436147A CN201410843780.6A CN201410843780A CN104436147A CN 104436147 A CN104436147 A CN 104436147A CN 201410843780 A CN201410843780 A CN 201410843780A CN 104436147 A CN104436147 A CN 104436147A
- Authority
- CN
- China
- Prior art keywords
- weight portion
- radix
- medicine composition
- blood
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 32
- 229940079593 drug Drugs 0.000 title claims description 11
- 208000003351 Melanosis Diseases 0.000 title abstract description 10
- 206010008570 Chloasma Diseases 0.000 title abstract description 9
- 239000000203 mixture Substances 0.000 title abstract description 7
- 241000221377 Auricularia Species 0.000 claims description 7
- 241000628997 Flos Species 0.000 claims description 7
- 239000009636 Huang Qi Substances 0.000 claims description 7
- 239000008194 pharmaceutical composition Substances 0.000 claims description 6
- 230000000694 effects Effects 0.000 abstract description 16
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 241001061264 Astragalus Species 0.000 abstract 1
- 240000006432 Carica papaya Species 0.000 abstract 1
- 235000009467 Carica papaya Nutrition 0.000 abstract 1
- 235000017643 Elaeagnus angustifolia Nutrition 0.000 abstract 1
- 244000016119 Elaeagnus latifolia Species 0.000 abstract 1
- 235000001456 Elaeagnus latifolia Nutrition 0.000 abstract 1
- 235000007630 Elaeagnus umbellata var parvifolia Nutrition 0.000 abstract 1
- 241000233866 Fungi Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 241000735234 Ligustrum Species 0.000 abstract 1
- 229930195210 Ophiopogon Natural products 0.000 abstract 1
- 244000248557 Ophiopogon japonicus Species 0.000 abstract 1
- 235000004789 Rosa xanthina Nutrition 0.000 abstract 1
- 241000109329 Rosa xanthina Species 0.000 abstract 1
- 235000017276 Salvia Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 244000273928 Zingiber officinale Species 0.000 abstract 1
- 235000006886 Zingiber officinale Nutrition 0.000 abstract 1
- 210000003056 antler Anatomy 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 235000008397 ginger Nutrition 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 210000004233 talus Anatomy 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 18
- 210000004369 blood Anatomy 0.000 description 18
- 210000004185 liver Anatomy 0.000 description 13
- 210000004072 lung Anatomy 0.000 description 10
- 210000000952 spleen Anatomy 0.000 description 8
- 230000017531 blood circulation Effects 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 6
- 239000007788 liquid Substances 0.000 description 5
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 3
- 230000002950 deficient Effects 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 230000002124 endocrine Effects 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000002612 cardiopulmonary effect Effects 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 230000008451 emotion Effects 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 206010003591 Ataxia Diseases 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- 230000035568 catharsis Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 1
- 150000002216 flavonol derivatives Chemical class 0.000 description 1
- 235000011957 flavonols Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 208000016290 incoordination Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/638—Ligustrum, e.g. Chinese privet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/732—Chaenomeles, e.g. flowering quince
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/738—Rosa (rose)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/37—Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicine composition for treating chloasma. The medicine composition comprises salvia, papaya, angelica, astragalus, black fungi, pungent oleaster root, privet, liquorice, ophiopogon, pilose antler, dried ginger and roses. The medicine composition has the advantages of fast effect, short treatment period, effective rate and high curative rate, is convenient to use, has no toxic and side effects, and is applicable to various people suffering from chloasma at different degrees.
Description
Technical field
The invention belongs to tcm field, particularly relate to a kind of pharmaceutical composition for the treatment of yellowish-brown pinta.
Background technology
Chloasma is a kind of common dermatosis, commonplace, distribute wide, fall ill in recent years on the rise, that a kind of skin of generally acknowledging both at home and abroad coagulates difficult disease, the numerous patient of grievous injury is physically and mentally healthy and attractive in appearance, the method of current this disease for the treatment of and medicine a lot, but can not reach Preferred effects, and the living and diet of modern people is too meticulous, quantity of motion reduces, or eating and drinking too much at one meal, or overstrain, body metabolism function is failed gradually, cause visceral dysfunction, easily cause the pigmented lesion such as chloasma faciei, freckle.The traditional Chinese medical science is thought, facial colour spot is that blood deficiency is not dissolved in face because of zang-fu differentiation qi and blood disorder; Or because of internal injury caused by excess of seven emotions, stagnation of QI due to depression of the liver, incoordination between the liver and spleen; Or because of improper diet and overtiredness, menoxenia; Or because of the blood system of fire stagnation meridians, ailment said due to cold or exposure is rich outward and caused by sending out.Adopt this kind of disease of western medicine, be mostly outer wiping or vitamins for oral administration, flavonols medicine.Because pathogenesis is more, adopt western medicine effect to differ, also not easily effect a radical cure, some medicine side effect is larger.
Summary of the invention
Technical problem to be solved by this invention is to provide a kind ofly has instant effect, treatment phase short, effective percentage and the high feature of healing, easy to use, nontoxic, a new generation's treatment chloasma medicine compositions of having no side effect.
The pharmaceutical composition of the yellowish-brown pinta for the treatment of provided by the invention, comprises following bulk drugs component and weight portion thereof: Radix Salviae Miltiorrhizae 50-80 weight portion, Fructus Chaenomelis 10-30 weight portion, Radix Angelicae Sinensis 30-50 weight portion, the Radix Astragali 15-45 weight portion, Auricularia 15-45 weight portion, Radix Elaeagni 55-85 weight portion, Fructus Ligustri Lucidi 15-45 weight portion, Radix Glycyrrhizae 5-10 weight portion, Radix Ophiopogonis 20-50 weight portion, Cornu Cervi Pantotrichum 10-20 weight portion, Rhizoma Zingiberis 20-30 weight portion, Flos Rosae Rugosae 10-50 weight portion.
The pharmaceutical composition of the yellowish-brown pinta for the treatment of provided by the invention, more preferably raw material components weight portion is: Radix Salviae Miltiorrhizae 50 weight portion, Fructus Chaenomelis 10 weight portion, Radix Angelicae Sinensis 35 weight portion, the Radix Astragali 20 weight portion, Auricularia 20 weight portion, Radix Elaeagni 60 weight portion, Fructus Ligustri Lucidi 20 weight portion, Radix Glycyrrhizae 5 weight portion, Radix Ophiopogonis 25 weight portion, Cornu Cervi Pantotrichum 10 weight portion, Rhizoma Zingiberis 25 weight portion, Flos Rosae Rugosae 30 weight portion.
In the present invention
Rhizoma Zingiberis: pungent, heat, returns spleen, stomach, the heart, lung meridian.Warming spleen and stomach for dispelling cold, recuperating depleted YANG is promoted blood circulation, warming the lung to resolve fluid-retention.
Radix Ophiopogonis: enter cardiopulmonary, stomach is through energy nourishing YIN and moistening the lung, and promote the production of body fluid stomach reinforcing, and clear away heart-fire effect of eliminating the phlegm.
Radix Salviae Miltiorrhizae: enter conscience warp, energy promoting blood flow to regulate menstruation, stasis-dispelling and pain-killing, evacuation of pus is subsided a swelling, tranquilizing by nourishing the heart, healthy and strong blood, the effect of conciliation.
Fructus Chaenomelis: have dehumidifying relaxing muscles and tendons and activating QI and blood in the collateral, regulates the effect that meridians stretch.
The Radix Astragali: warm in nature is the key medicine of a QI invigorating, and the functional recovery of lacking of proper care mutually can be made normal.And have cardiotonic.
Radix Angelicae Sinensis: warm in nature, sweet in the mouth is pungent.GUIXIN, liver, spleen channel.Enrich blood and invigorate blood circulation, menstruction regulating and pain relieving, loosening bowel to relieve constipation.
Radix Elaeagni: evergreen shrubs, the Radix Elaeagni of this plant.Nature and flavor acid, nontoxic, be in harmonious proportion spleen, dissipating blood stasis removing toxic substances is because there is regulating the liver and spleen to adjust the effect of stomach, tonification the five internal organs.
Fructus Ligustri Lucidi: enter liver, kidney channel the kidney invigorating, strong waist lower limb, controls yin asthenia generating intrinsic heat, effect of order flower tinnitus.
Auricularia: sweet in the mouth, property are flat, return stomach, large intestine channel.There is QI invigorating, lung moistening, supplementing the brain, make light of one's life by commiting suicide, removing heat from blood, hemostasis, astringing intestine to stop diarrhea, invigorate blood circulation, Qiang Zhi, support the effect such as appearance.
Radix Glycyrrhizae: enter the heart, spleen channel, the effect of lung moistening coordinating the actions of various ingredients in a prescription removing toxic substances.
Flos Rosae Rugosae: property is sweet, mildly bitter flavor, temperature.Return liver, spleen channel, have promoting QI circulation for relieving depression, effect of promoting blood circulation and stopping pain.
Cornu Cervi Pantotrichum: kidney invigorating and YANG supporting.
According to the yellowish-brown pinta for the treatment of provided by the invention pharmaceutical composition described in yellowish-brown pinta be caused by damaged by excess of seven emotions according to Chinese medicine, the cause of disease is intricate.Mainly blood or a blood circulation, or endocrine disturbance road causes reason.The obstructed imbalance of QI and blood, by the hepatic and renal YIN deficiency, causes blood not support skin, and SHENGHUANG brown patch, informs that blood is good, the good light of skin and flesh has pool from our ancestors, proves that chloasma and blood and endocrine are closely related.Doctor trained in Western medicine be due to people immune system dysfunction lowly caused by.Really be divide caused reason of must lacking of proper care in liver, this is that medical circle generally acknowledges a fact.The healthy energy of people refers to that each function of organization of the vital organs of the human body is prosperous and reaches.QI and blood is sufficient, equilibrium between yin and yang, an important step on healthy energy lung.The convergence of vessels in the lung, our ancestors just know in one's early years and have separated, and time normal, skin gloss has face.The growth of hair is all by depending on lung qi Wen Zhao.Lung governing qi simultaneously, blood circulation depending on qi flow, demonstrates lung relevant with chloasma.
The blood stored in the liver of speech, to be that blood is logical be linked to cardiopulmonary liver to arteries and veins, and susceptible to anger is sad in liver, because liver is store blood, catharsis endocrine bile and regulating action, return former store blood to be main.Can have one's ideas straightened out in order again, black dull now, night is insomnia, chloasma and liver direct relation, demonstrates and adjusts blood because of the Chinese medicine from liver.
The formula of these crude drug above-mentioned (or claiming Chinese herbal medicine) component composition, all has commercially available.The comprehensive compatibility of prescription, cooperatively interacts as with, synergism, had both played the unique effects that single component medicine has, again one each other, greatly promotes that drug effect improves, and makes cure rate and effective percentage greatly improve, and shortens treatment cycle.
Detailed description of the invention
The present invention's the following example further illustrates the present invention.
EXAMPLE l
By marketable material medicine respectively through selected, remove defective crude drug and impurity is cleaned again, through sterilization treatment crude drug after drying: Radix Salviae Miltiorrhizae 5kg, Fructus Chaenomelis lkg, Radix Angelicae Sinensis 3.5kg, Radix Astragali 2kg, Auricularia 2kg, Radix Elaeagni 6kg, Fructus Ligustri Lucidi 2kg, Radix Glycyrrhizae 0.5kg, Radix Ophiopogonis 2.5kg, Cornu Cervi Pantotrichum lkg, Rhizoma Zingiberis 2.5kg, Flos Rosae Rugosae 3kg mixture is put into infuser device and is soaked in water, the consumption of water is as the criterion to soak powder stock medicine, after covering tightly sealing, ten days are soaked in less than 10 DEG C ventilating and cooling places, take out medicinal liquid, be filtered into pure clear liquid medicine, then in every bag of 200 milliliters of plastic bags, pure clear liquid medicine oral liquid medicine is become with filling apparatus fill after aseptic process, instructions of taking: every twice-daily, each one bag.
Embodiment 2
By each marketable material medicine respectively through selected, remove defective crude drug and impurity, clean the dry crude drug after drying and sterilizing process again: Radix Salviae Miltiorrhizae 65 grams, Fructus Chaenomelis 20 grams, Radix Angelicae Sinensis 40 grams, the Radix Astragali 35 grams, Auricularia 30 grams, Radix Elaeagni 70 grams, Fructus Ligustri Lucidi 40 grams, 8 grams, Radix Glycyrrhizae, Radix Ophiopogonis 40 grams, 15 grams, Cornu Cervi Pantotrichum, Rhizoma Zingiberis 25 grams, Flos Rosae Rugosae 45 grams be placed on common pottery fill with in slow fire boiling 2 hours, leach 300 to 400 milliliters of medicinal liquids, it is oral dose on the one, directly oral, instructions of taking a: twice-daily, each 150 milliliters-200 milliliters.
Embodiment 3
By each following bulk drugs commercially available respectively through selected, remove defective crude drug and impurity is cleaned again, dry in drying plant, carry out the dry crude drug after aseptic process again: Radix Salviae Miltiorrhizae 8kg, Fructus Chaenomelis 3kg, Radix Angelicae Sinensis 5kg, Radix Astragali 4.5kg, Auricularia 4.5kg, Radix Elaeagni 8.5kg, Fructus Ligustri Lucidi 4.5kg, Radix Glycyrrhizae lkg, Radix Ophiopogonis 5kg, Cornu Cervi Pantotrichum 2kg, Rhizoma Zingiberis 3kg, Flos Rosae Rugosae 5kg, according to making an instant medicine material in " whole part " extraction equipment, and fill with in 3-5 grams every bag sealed, sterile bags.Instructions of taking: every day 2 bags, each one bag.
Claims (1)
1. treat a pharmaceutical composition for yellowish-brown pinta, comprise following bulk drugs component and weight portion thereof: Radix Salviae Miltiorrhizae 50-80 weight portion, Fructus Chaenomelis 10-30 weight portion, Radix Angelicae Sinensis 30-50 weight portion, the Radix Astragali 15-45 weight portion, Auricularia 15-45 weight portion, Radix Elaeagni 55-85 weight portion, Fructus Ligustri Lucidi 15-45 weight portion, Radix Glycyrrhizae 5-10 weight portion, Radix Ophiopogonis 20-50 weight portion, Cornu Cervi Pantotrichum 10-20 weight portion, Rhizoma Zingiberis 20-30 weight portion, Flos Rosae Rugosae 10-50 weight portion.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410843780.6A CN104436147A (en) | 2014-12-31 | 2014-12-31 | Medicine composition for treating chloasma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410843780.6A CN104436147A (en) | 2014-12-31 | 2014-12-31 | Medicine composition for treating chloasma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104436147A true CN104436147A (en) | 2015-03-25 |
Family
ID=52883407
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410843780.6A Pending CN104436147A (en) | 2014-12-31 | 2014-12-31 | Medicine composition for treating chloasma |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104436147A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102908530A (en) * | 2012-10-16 | 2013-02-06 | 周岳松 | Oral medicine for treating chloasma and preparation method of same |
| CN104056222A (en) * | 2014-06-16 | 2014-09-24 | 程泽莉 | Menstruation-regulating beauty tonic pill |
-
2014
- 2014-12-31 CN CN201410843780.6A patent/CN104436147A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102908530A (en) * | 2012-10-16 | 2013-02-06 | 周岳松 | Oral medicine for treating chloasma and preparation method of same |
| CN104056222A (en) * | 2014-06-16 | 2014-09-24 | 程泽莉 | Menstruation-regulating beauty tonic pill |
Non-Patent Citations (2)
| Title |
|---|
| 刘海燕等: ""陈明岭教授治疗黄褐斑临床经验"", 《四川中医》 * |
| 梁勇: "补益肝肾与活血化瘀法治疗黄褐斑200例", 《吉林中医药》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100339123C (en) | Traditional Chinese medicine liquor and preparation method thereof | |
| CN103349753B (en) | Traditional Chinese medicine composition for treating kidney deficiency | |
| CN102920846A (en) | Yaowang health wine and preparation method of the Yaowang health wine | |
| CN102698093A (en) | Chinese medicinal composition for treating liver and kidney deficiency type hypertension and preparation method thereof | |
| CN103007217B (en) | Chinese medicinal composition for treating hypotension | |
| CN104474298A (en) | Traditional Chinese medicine for treating vitiligo | |
| CN104623232A (en) | Traditional Chinese medicine composition for treating tinnitus | |
| CN103860812A (en) | Chinese medicine composition for treating deficiency of kidney-yang | |
| CN103816485A (en) | Traditional Chinese medicine composition for treating scleredema neonatorum and preparation method of traditional Chinese medicine composition | |
| CN103251889A (en) | Traditional Chinese medicine composition for treating agalactia | |
| CN103463588A (en) | Traditional Chinese medicine composition for treating sinking of qi of middle-jiao | |
| CN103330814B (en) | A kind of Chinese medicine composition for the treatment of insufficiency of kidney-YANG | |
| CN105617198A (en) | Method for preparing medicinal liquor for treating wind-cold low back pain | |
| CN104436147A (en) | Medicine composition for treating chloasma | |
| CN104547642A (en) | Tradtional Chinese medicine composition for treating female fibromyalgia syndromes | |
| CN104042839A (en) | Traditional Chinese medicine composition for treating tinea versicolor | |
| CN108938813A (en) | The Traditional Chinese medicine footbath agent and its application method for treating diabetes complicated property toe end necrosis | |
| CN103638469B (en) | A kind of Chinese medicine for the treatment of coronary heart disease | |
| CN102614484B (en) | Bathing traditional Chinese medicine for adjuvant therapy of cerebral thrombosis and hypertension and method for preparing same | |
| CN102908530B (en) | Oral medicine for treating chloasma and preparation method of same | |
| CN102406879A (en) | Chinese medicine composition for treating rhinitis | |
| CN106110152A (en) | A kind of damp eliminating fat is regulated the flow of vital energy granule | |
| CN105267862A (en) | Traditional Chinese medicine composition for treating ventricular premature beat | |
| CN104758539A (en) | Traditional Chinese medicine composition for treating debilitation | |
| CN103028104B (en) | Traditional Chinese medicine composition for treating abdominal pain |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150325 |